Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Skaggs

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Journal of Rheumatology|April 1, 2026
Rethinking Cardiovascular Screening in Systemic Lupus ErythematosusMaureen McMahon, Brian J Skaggs
Rheumatology and Immunology Research|July 26, 2022
Cardiovascular disease in systemic lupus erythematosusMaureen McMahon, Richard Seto, Brian J Skaggs
Nature Reviews. Rheumatology|February 15, 2012
Accelerated atherosclerosis in patients with SLE--mechanisms and managementBrian J Skaggs, Bevra H Hahn, Maureen McMahon
Expert Review of Clinical Immunology|March 24, 2011
Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic interventionMaureen McMahon, Bevra H Hahn, Brian J Skaggs
Human Immunology|September 27, 2008
Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone miceBrian J Skaggs, Ram Pyare Singh, Bevra H Hahn
Clinical Immunology (Orlando, Fla.)|July 20, 2010
Dysfunctional, pro-inflammatory HDL directly upregulates monocyte PDGFRβ, chemotaxis and TNFα productionBrian J Skaggs, Bevra H Hahn, Lori Sahakian, et al.
Arthritis Research & Therapy|October 3, 2008
Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritisBevra H Hahn, Jennifer Grossman, Benjamin J Ansell, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2005
Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistanceMichael R Burgess, Brian J Skaggs, Neil P Shah, et al.
Autoimmunity Reviews|April 14, 2010
CD8+ Tregs in lupus, autoimmunity, and beyondRavi K Dinesh, Brian J Skaggs, Antonio La Cava, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cellsElaine V Lourenço, Maida Wong, Bevra H Hahn, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Journal of Rheumatology|April 1, 2026
Rethinking Cardiovascular Screening in Systemic Lupus ErythematosusMaureen McMahon, Brian J Skaggs
Rheumatology and Immunology Research|July 26, 2022
Cardiovascular disease in systemic lupus erythematosusMaureen McMahon, Richard Seto, Brian J Skaggs
Nature Reviews. Rheumatology|February 15, 2012
Accelerated atherosclerosis in patients with SLE--mechanisms and managementBrian J Skaggs, Bevra H Hahn, Maureen McMahon
Expert Review of Clinical Immunology|March 24, 2011
Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic interventionMaureen McMahon, Bevra H Hahn, Brian J Skaggs
Human Immunology|September 27, 2008
Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone miceBrian J Skaggs, Ram Pyare Singh, Bevra H Hahn
Clinical Immunology (Orlando, Fla.)|July 20, 2010
Dysfunctional, pro-inflammatory HDL directly upregulates monocyte PDGFRβ, chemotaxis and TNFα productionBrian J Skaggs, Bevra H Hahn, Lori Sahakian, et al.
Arthritis Research & Therapy|October 3, 2008
Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritisBevra H Hahn, Jennifer Grossman, Benjamin J Ansell, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2005
Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistanceMichael R Burgess, Brian J Skaggs, Neil P Shah, et al.
Autoimmunity Reviews|April 14, 2010
CD8+ Tregs in lupus, autoimmunity, and beyondRavi K Dinesh, Brian J Skaggs, Antonio La Cava, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cellsElaine V Lourenço, Maida Wong, Bevra H Hahn, et al.
Pageof 2